Synopsys 超过了2025年第三季度的财报预期，提高了2026年的财报指引，并实现了机构采购的增加。 Synopsys beat Q3 2025 earnings estimates, raised 2026 guidance, and saw increased institutional buying.

Synopsys公布了强劲的2025年第三季度业绩，每股收益为290美元，超出预期0.11美元，收入达到22.5亿美元，同比增长37.8%。 Synopsys reported strong Q3 2025 results with $2.90 EPS, beating estimates by $0.11, and $2.25 billion in revenue, up 37.8% year-over-year. 该公司将2026年全年指导提高到14.32至14.40美元的EPS,将2026年第一季度展望提高到3.52至3.58美元的EPS。 The company raised full-year 2026 guidance to $14.32–$14.40 EPS and first-quarter 2026 outlook to $3.52–$3.58 EPS. 机构投资者增加了股份,Harel保险公司增加了2 596万美元,Hapoalim银行增加了262.1%。 Institutional investors increased their stake, with Harel Insurance adding $25.96 million and Bank Hapoalim boosting its position by 262.1%. TD 私人客户财富将其持有的股份减少到455股。 TD Private Client Wealth reduced its holding to 455 shares. 2026年1月17日的股票交易额为516.31美元,市场上限为987.8亿美元,P/E比率为64.62。 The stock traded at $516.31 on January 17, 2026, with a market cap of $98.78 billion and a P/E ratio of 64.62. 分析员维持协商一致的“等待”评级,目标为553.57美元。 Analysts maintain a consensus "Hold" rating with a target of $553.57.